Isabelle Girault
OSE Immunotherapeutics (France)(FR)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, Melanoma and MAPK Pathways, CAR-T cell therapy research, Immune Cell Function and Interaction
Most-Cited Works
- → Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study(2013)990 cited
- → eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies(2014)354 cited
- → Translational control of tumor immune escape via the eIF4F–STAT1–PD-L1 axis in melanoma(2018)258 cited
- → Tumor-associated high endothelial venules mediate lymphocyte entry into tumors and predict response to PD-1 plus CTLA-4 combination immunotherapy(2022)239 cited
- → Acute Plasma Biomarkers of T Cell Activation Set-Point Levels and of Disease Progression in HIV-1 Infection(2012)146 cited
- → Hiv-1 Control after Transient Antiretroviral Treatment Initiated in Primary Infection: Role of Patient Characteristics and Effect of Therapy(2012)132 cited
- → Increased CD127 expression on activated FOXP3+CD4+ regulatory T cells(2010)121 cited
- → Targeting the Deregulated Spliceosome Core Machinery in Cancer Cells Triggers mTOR Blockade and Autophagy(2013)104 cited
- → Selective SIRPα blockade reverses tumor T cell exclusion and overcomes cancer immunotherapy resistance(2020)93 cited
- → Potential Role for HIV-Specific CD38−/HLA-DR+ CD8+ T Cells in Viral Suppression and Cytotoxicity in HIV Controllers(2014)88 cited